From June 18th to 20th, 2024, local time in Stuttgart Germany, PT Medtech made its debut at the world-renowned medical device technology exhibition MedtecLIVE2024, with booth number 1-122. The exhibition was grandly held at the Stuttgart Exhibition Center in Germany. During the event, PT MedTech showcased to global medical industry experts and scholars the company's rich experience accumulated over 20 years in the medical field, including energy surgery, endoscopic surgery, ophthalmology, orthopedics, interventional solutions, and surgical robotics. PT MedTech also demonstrated its achievements in high-precision machining, precision injection molding, medical-grade electronic manufacturing, and finished product assembly in a 100,000-class clean room, providing more high-quality options for domestic and international brand manufacturers participating in the exhibition.

MedtecLIVE is Europe's leading medical technology development and manufacturing exhibition and the second largest world conference in the medical device industry. The total exhibition area exceeds 20,000 square meters. There are more than 390 exhibitors from the world and nearly 20,000 visitors. During the exhibition, PT Medtech team had face-to-face communication with many potential global medical device customers at the booth. Customers showed great interest in PT Medtech's processing capabilities and appreciated PT Medtech's vertical integration processing capabilities. At the same time, at this exhibition, the company also met with old customers whom have long-term business relationship, which consolidated the foundation for cooperation between the two parties, demonstrated the company's strength, and further enhanced the confidence of both parties in long-term cooperation.

This exhibition is a preliminary attempt by PT Medtech to expand its business in Europe. The company will take this opportunity to continue to explore European market, expand the company's influence, strengthen the European customers base, and lay a solid foundation for the company's future development.